| Source: |
| Type: |
| The GCLC gene (Glutamate-Cysteine Ligase, Catalytic Subunit) is a key regulator of glutathione synthesis, and its expression has been studied in various types of cancer. GCLC gene has been found to be: Amplified in 15% of breast cancer cases Mutated in 5% of lung cancer cases Deleted in 10% of prostate cancer cases Methylated in 20% of colorectal cancer cases |
| Colorectal cancer is a broader term that encompasses both colon and rectal cancer. |
| 1009- | And, | 5-FU, | Andrographis-mediated chemosensitization through activation of ferroptosis and suppression of β-catenin/Wnt-signaling pathways in colorectal cancer |
| - | in-vivo, | CRC, | HCT116 | - | in-vitro, | CRC, | SW480 |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:6 Cells:% prod#:% Target#:966 State#:% Dir#:2
wNotes=0 sortOrder:rid,rpid